This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Nov 26;527(7579):S217.

doi: 10.1038/527S217a.

Ovarian cancer: beyond resistance

PMID: 26605761
DOI: 10.1038/527S217a

Ovarian cancer: beyond resistance

David Holmes. Nature. 2015.

. 2015 Nov 26;527(7579):S217.

doi: 10.1038/527S217a.

Author

PMID: 26605761
DOI: 10.1038/527S217a

No abstract available

PubMed Disclaimer

Similar articles

The problem with platinum.
Holmes D. Holmes D. Nature. 2015 Nov 26;527(7579):S218-9. doi: 10.1038/527S218a. Nature. 2015. PMID: 26605762 No abstract available.
[CA-125 as response parameter in ovarian carcinoma].
Zirpel I, Illiger HJ. Zirpel I, et al. Strahlenther Onkol. 2000 Apr;176(4):200. Strahlenther Onkol. 2000. PMID: 10841742 German. No abstract available.
The prognostic nomogram in platinum-resistant ovarian cancer: how to develop and validate?
Wen KC, Sung PL, Lai HC. Wen KC, et al. Chin Clin Oncol. 2021 Jun;10(3):31. doi: 10.21037/cco-2020-002. Epub 2020 Jul 7. Chin Clin Oncol. 2021. PMID: 32648447 No abstract available.
Treatment of recurrent ovarian cancer relapsing 6-12 months post platinum-based chemotherapy.
Colombo N, Gore M. Colombo N, et al. Crit Rev Oncol Hematol. 2007 Nov;64(2):129-38. doi: 10.1016/j.critrevonc.2007.04.004. Epub 2007 Jun 12. Crit Rev Oncol Hematol. 2007. PMID: 17566758 Review.
Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.
Modesitt SC, Jazaeri AA. Modesitt SC, et al. Expert Opin Pharmacother. 2007 Oct;8(14):2293-305. doi: 10.1517/14656566.8.14.2293. Expert Opin Pharmacother. 2007. PMID: 17927484 Review.

See all similar articles

Cited by

Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell Death.
Guo F, Yang Z, Sehouli J, Kaufmann AM. Guo F, et al. Curr Oncol. 2022 Apr 16;29(4):2808-2822. doi: 10.3390/curroncol29040229. Curr Oncol. 2022. PMID: 35448203 Free PMC article.
Identification and Characterization of a New Platinum-Induced TP53 Mutation in MDAH Ovarian Cancer Cells.
Lorenzon I, Pellarin I, Pellizzari I, D'Andrea S, Belletti B, Sonego M, Baldassarre G, Schiappacassi M. Lorenzon I, et al. Cells. 2019 Dec 21;9(1):36. doi: 10.3390/cells9010036. Cells. 2019. PMID: 31877751 Free PMC article.
Expression and function of FRA1 protein in tumors.
Jiang X, Xie H, Dou Y, Yuan J, Zeng D, Xiao S. Jiang X, et al. Mol Biol Rep. 2020 Jan;47(1):737-752. doi: 10.1007/s11033-019-05123-9. Epub 2019 Oct 14. Mol Biol Rep. 2020. PMID: 31612408 Review.
Epithelial ovarian cancer: feasibility of image-guided intratumoral radiofrequency hyperthermia-enhanced direct gene therapy.
Jin G, Li Y, Zhang F, Li P, Zhao L, Zhou Y, Ji H, Pietrini S, Zhai B, Yang X. Jin G, et al. Am J Cancer Res. 2019 Feb 1;9(2):378-389. eCollection 2019. Am J Cancer Res. 2019. PMID: 30906635 Free PMC article.
Regulator of Chromosome Condensation 2 Modulates Cell Cycle Progression, Tumorigenesis, and Therapeutic Resistance.
Guo K, Zhao C, Lang B, Wang H, Zheng H, Zhang F. Guo K, et al. Front Mol Biosci. 2021 Jan 13;7:620973. doi: 10.3389/fmolb.2020.620973. eCollection 2020. Front Mol Biosci. 2021. PMID: 33521058 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information